Clinical Trial Update: Efficacy and Safety Study of E2007 in Migraine Prophylaxis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of E2007 for migraine prophylaxis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• E2007

Snippet

Sponsor: Eisai Inc. | Conditions: Migraine Prophylaxis | Phase 2 | Status: COMPLETED | Results posted: 2015-06-08